News . Data . Research
Alnylam Pharmaceuticals Inc (ALNY) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Christine Regan Lindenboom -- Vice President, Investor Relations and Corporate
Bausch Health Companies Inc. (NYSE: BHC) reported a wider loss in the first quarter of 2020 due to lower income taxes benefit
Horizon Therapeutics PLC (HZNP) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Tina Ventura -- Senior Vice President, Investor Relations Tim Walbert -- Chairman,
Bristol-Myers Squibb Company (NYSE: BMY) reported first-quarter 2020 financial results before the regular trading hours on Thursday. The results were better than
Teva Pharmaceuticals' (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share on revenue
Tivity Health, Inc. (TVTY) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Bob Greczyn -- Interim Chief Executive Officer Steve Janicak -- President of
CVS Health Corp. (CVS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President, Investor Relations Larry
Alexion Pharmaceuticals Inc (ALXN) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Chris Stevo -- Head of Investor Relations Ludwig Hantson -- Chief Executive
CVS Health Corporation (NYSE: CVS) reported first quarter 2020 earnings results today. Total revenues increased 8.3% to $66.8 billion,driven mainly by strong
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market opens.
Alexion Pharmaceuticals (NASDAQ: ALXN) announced today that it will be acquiring commercial-stage biopharmaceutical company Portola Pharmaceuticals (NASDAQ: PTLA) for an initial consideration
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The
Varian Medical Systems Inc (VAR) Q2 2020 earnings call dated May 04, 2020 Corporate Participants: Anshul Maheshwari -- Vice President, Treasury and Investor Relations
AbbVie (NYSE: ABBV), which is expecting to close the acquisition of Allergan in this month, reported its first quarter 2020 earnings results
COVID-19 has been pretty disruptive on clinical-level biotech and pharmaceutical companies worldwide, especially those running on tight budgets. Clinical trials have been
PetMed Express Inc (PETS) Q4 2019 earnings call dated May. 04, 2020 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer and Treasurer Menderes
Novartis International AG (NVS) Q1 2020 earnings call dated Apr. 28, 2020 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant Narasimhan -- Chief
Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the
Viking Therapeutics Inc (VKTX) Q1 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Stephanie Diaz -- Manager, Investor Relations Brian Lian -- President and Chief
Baxter International Inc (BAX) Q1 2020 earnings call dated April 30, 2020 Corporate Participants: Clare Trachtman -- Vice President, Investor Relations Jose E. Almeida -- Chairman,
AbbVie Inc (ABBV) Q1 2020 earnings call dated May. 01, 2020 Corporate Participants: Liz Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of